Abstract
Purpose
High-grade gliomas (HGG) are aggressive cancers, and their recurrence is inevitable, despite advances in treatment options. While repeated tumor resection has been shown to increase survival rate, its impact on quality of life is not clearly defined. To address this gap, we compared quality of life (QoL) changes in HGG patients who underwent first-time (FTR) versus repeat surgical resections (RSR) for management of recurrence.
Methods
Forty-four adults with HGG who underwent tumor resection were included in this study and classified into either the FTR group (n = 23) or the RSR group (n = 21). All patients completed comprehensive neuropsychological evaluations that included the Functional Assessment of Cancer Therapy-General (FACT-G) and Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) scales, pre-operatively and at two weeks post-operatively.
Results
There was no difference between the FTR and RSR groups in any of the QoL indices (all p > .05), except for improved emotional well-being and worsened social well-being, suggesting minimal detrimental effects of repeat surgeries on QoL in comparison to first time surgery.
Conclusions
These results suggest that repeated resection is a viable strategy in certain cases for management of HGG recurrence, with similar impact on QoL as observed in patients undergoing first time surgery. These encouraging outcomes provide useful insight to guide treatment strategies and patient and clinician decision making to optimize surgical and functional outcomes.
Similar content being viewed by others
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS (2022) CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro-Oncol 24(Supplement_5):v1-v95. https://doi.org/10.1093/neuonc/noac202
Zhou X, Liao X, Zhang B, He H, Shui Y, Xu W, Jiang C, Shen L, Wei Q (2016) Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy. Mol Clin Oncol 5(2):289–294. https://doi.org/10.3892/mco.2016.936
Chaichana KL, Zadnik P, Weingart JD, Olivi A, Gallia GL, Blakeley J, Lim M, Brem H, Quiñones-Hinojosa A (2013) Multiple resections for patients with glioblastoma: prolonging survival. J Neurosurg 118(4):812–820. https://doi.org/10.3171/2012.9.JNS1277
Hong B, Wiese B, Bremer M, Heissler HE, Heidenreich F, Krauss JK, Nakamura M (2013) Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme. Am J Clin Oncol 36(3):261–268. https://doi.org/10.1097/COC.0b013e3182467bb1
Djamel-Eddine YC, De Witte O, Melot C, Lefranc F (2019) Recurrent glioblastomas: should we operate a second and even a third time? Interdisciplinary Neurosurgery 18:100551. https://doi.org/10.1016/j.inat.2019.100551
Ringel F, Pape H, Sabel M, Krex D, Bock HC, Misch M, Weyerbrock A, Westermaier T, Senft C, Schucht P, Meyer B, Simon M, SN1 study group (2016) Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection. Neuro Oncol 18(1):96-104.https://doi.org/10.1093/neuonc/nov145
Krajewski S, Furtak J, Zawadka-Kunikowska M, Kachelski M, Birski M, Harat M (2022) Rehabilitation outcomes for patients with motor deficits after initial and repeat brain tumor surgery. Int J Environ Res Public Health 19(17):10871. https://doi.org/10.3390/ijerph191710871
Yang K, Ellenbogen Y, Martyniuk A, Sourour M, Takroni R, Somji M, Gardiner E, Hui K, Odedra D, Larrazabal R, Algird A, Kachur E, Reddy K, Murty N, Farrokhyar F, Singh SK (2022) Reoperation in adult patients with recurrent glioblastoma: A matched cohort analysis. Neurooncol Adv 4(1):vdac115. https://doi.org/10.1093/noajnl/vdac115
Hoover JM, Nwojo M, Puffer R, Mandrekar J, Meyer FB, Parney IF (2013) Surgical outcomes in recurrent glioma: clinical article. J Neurosurg 118(6):1224–1231. https://doi.org/10.3171/2013.2.JNS121731
McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A (2009) Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 65(3):463–470. https://doi.org/10.1227/01.NEU.0000349763.42238.E9
Rahman M, Abbatematteo J, De Leo EK, Kubilis PS, Vaziri S, Bova F, Sayour E, Mitchell D, Quinones-Hinojosa A (2017) The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma. J Neurosurg 127(1):123–131. https://doi.org/10.3171/2016.7.JNS16396
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251. https://doi.org/10.1093/neuonc/noab106
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579. https://doi.org/10.1200/JCO.1993.11.3.570
Henneghan AM, Van Dyk K, Kaufmann T, Harrison R, Gibbons C, Heijnen C, Kesler SR (2021) Measuring self-reported cancer-related cognitive impairment: recommendations from the cancer neuroscience initiative working group. J Natl Cancer Inst 113(12):1625–1633. https://doi.org/10.1093/jnci/djab027
Dyk KV, Crespi CM, Petersen L, Ganz PA (2019) Identifying cancer-related cognitive impairment using the FACT-Cog perceived cognitive impairment. JNCI Cancer Spectr 4(1):pkz099. https://doi.org/10.1093/jncics/pkz099
Edianto D, Yaznil MR, Chartyansari AA, Effendi IH (2019) Assessment of the quality of life for gynecologic cancer patients using functional assessment of cancer therapy-general (Fact-G) questionnaire at Haji Adam Malik Hospital. Open Access Maced J Med Sci 7(16):2569–2573. https://doi.org/10.3889/oamjms.2019.391
Janelsins MC, Heckler CE, Peppone LJ, Kamen C, Mustian KM, Mohile SG, Magnuson A, Kleckner IR, Guido JJ, Young KL, Conlin AK, Weiselberg LR, Mitchell JW, Ambrosone CA, Ahles TA, Morrow GR (2016) Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a Nationwide, multicenter, Prospective Longitudinal Study. J Clin Oncol 35(5):506–514. https://doi.org/10.1200/JCO.2016.68.5826
King MT, Cella D, Osoba D, Stockler M, Eton D, Thompson J, Eisenstein A (2010) Meta-analysis provides evidence-based interpretation guidelines for the clinical significance of mean differences for the FACT-G, a cancer-specific quality of life questionnaire. Patient Relat Outcome Meas 1:119–126. https://doi.org/10.2147/PROM.S10621
Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L, Winocur G, De Ruiter MB, Castel H (2019) Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol 30(12):1925–1940. https://doi.org/10.1093/annonc/mdz410
Yost KJ, Thompson CA, Eton DT, Allmer C, Ehlers SL, Habermann TM, Shanafelt TD, Maurer MJ, Slager SL, Link BK, Cerhan JR (2013) The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma. Leuk Lymphoma 54(2):290–297. https://doi.org/10.3109/10428194.2012.711830
Beck AT, Steer RA, Brown GK (1996) Manual for the Beck depression inventory-II. Psychological Corporation, San Antonio, Texas
Beck AT, Steer RA (1993) Beck anxiety inventory. Psychological Corporation, San Antonia, Texas
McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinoñes-Hinojosa A (2008) Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 63(4):700–708. https://doi.org/10.1227/01.NEU.0000325729.41085.73
Pertz M, Schlegel U, Thoma P (2022) Sociocognitive functioning and psychosocial burden in patients with brain tumors. Cancers 14(3):767. https://doi.org/10.3390/cancers14030767
Jenkins LM, Drummond KJ, Andrewes DG (2016) Emotional and personality changes following brain tumour resection. J Clin Neurosci 29:128–213. https://doi.org/10.1016/j.jocn.2015.12.007
Cuevas H, Danesh V, Henneghan A (2022) Self-reported cognitive function in persons with nonneurological chronic diseases: a systematic review. J Aging Res 2022:5803337. https://doi.org/10.1155/2022/5803337
Ramasubbu SK, Pasricha RK, Nath UK, Rawat VS, Das B (2021) Quality of life and factors affecting it in adult cancer patients undergoing cancer chemotherapy in a tertiary care hospital. Cancer Rep (Hoboken) 4(2):e1312. https://doi.org/10.1002/cnr2.1312
Funding
AQH acknowledges support from the William J. and Charles H. Mayo Professorship, the Mayo Clinic Clinician Investigator Award, the Florida Department of Health Cancer Research Chair Fund, and the Monica Flynn Jacoby Endowed Chair, NIH R01CA282451, NIH R01NS129671 and NIH R01CA284268.
Author information
Authors and Affiliations
Contributions
J.M.K. and D.S.S. contributed to the study conception and design. Material preparation and data collection were performed by J.M.K., L.M., D.M.G., A.Q.H., K.C., J.P.C.A., D.S.S. Analysis were performed by J.M.K. and D.S.S. The first draft of the manuscript was written by J.M.K. and D.S.S. All authors critically reviewed and revised the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
This study was approved by the Mayo Clinic Institutional Review Board (IRB# 16–009946).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Koay, J.M., Michaelides, L., Moniz-Garcia, D.P. et al. Repeated surgical resections for management of high-grade glioma and its impact on quality of life. J Neurooncol 167, 267–273 (2024). https://doi.org/10.1007/s11060-024-04600-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-024-04600-x